Impact of Biosimilar Competition on Out-of-Pocket Costs for Biologics

from TheBrief.Health · host TheBrief.Health

Biosimilar competition lowers out-of-pocket costs for Medicare patients on biologics, improving access, adherence, and outcomes while helping healthcare systems reduce spending on high-cost therapies.

Episode metadata supplied by the publisher feed · Published Mar 31, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Impact of Biosimilar Competition on Out-of-Pocket Costs for Biologics

0:00 1:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on March 31, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!